CITIGROUP INC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 73 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26,398
+80.1%
88,5850.0%0.00%
Q2 2023$14,661
-83.0%
88,5850.0%0.00%
Q1 2023$86,459
-6.2%
88,585
-0.0%
0.00%
Q4 2022$92,160
-19.2%
88,615
-10.7%
0.00%
Q3 2022$114,000
-86.3%
99,187
-77.7%
0.00%
-100.0%
Q2 2022$830,000
-42.7%
444,095
-7.1%
0.00%0.0%
Q1 2022$1,448,000
-22.2%
477,960
-3.0%
0.00%0.0%
Q4 2021$1,862,000
-24.0%
492,494
+3.9%
0.00%0.0%
Q3 2021$2,450,000
+54.8%
473,816
+14.6%
0.00%0.0%
Q2 2021$1,583,000
+52.2%
413,350
+2.2%
0.00%0.0%
Q1 2021$1,040,000
+1.5%
404,548
-1.4%
0.00%0.0%
Q4 2020$1,025,000
+23.0%
410,118
+2.0%
0.00%0.0%
Q3 2020$833,000
-33.9%
402,246
-1.1%
0.00%0.0%
Q2 2020$1,261,000
+33.4%
406,824
-1.8%
0.00%0.0%
Q1 2020$945,000
+2525.0%
414,385
+4050.9%
0.00%
Q4 2019$36,000
+50.0%
9,983
+42.1%
0.00%
Q3 2019$24,000
-60.7%
7,024
-45.8%
0.00%
Q2 2019$61,000
+29.8%
12,966
-7.9%
0.00%
Q1 2019$47,000
+27.0%
14,078
+3.3%
0.00%
Q4 2018$37,000
-53.8%
13,626
-4.4%
0.00%
Q3 2018$80,000
+110.5%
14,254
+91.1%
0.00%
Q2 2018$38,000
+26.7%
7,458
+69.8%
0.00%
Q1 2018$30,000
+1400.0%
4,392
+1330.6%
0.00%
Q4 2017$2,000
+100.0%
307
+186.9%
0.00%
Q3 2017$1,000107
+23.0%
0.00%
Q2 2017$087
-41.2%
0.00%
Q1 2016$01480.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders